Skip to content

Anja Meyer

2 papers in the library · publishing 2002

Papers

Sort Most recent Most cited

Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.

Neuroscience Letters September 27, 2002 Anja Meyer, Andreas Mayerhofer, Karl‐artur Kovar et al.

3,4-methylenedioxy-methylamphetamine (MDMA) ('Ecstasy') and its analogue 3,4-methylenedioxy-methylamphetamine (MDE) ('Eve') are well known illicit street drugs mainly abused by young people. In spite of the actual research going on, the classification of their abuse potential remains unclear. Since secondary reinforcers are the main factors responsible for craving and relapse, the aim of our...

Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?

Neuroscience Letters September 27, 2002 Werner J Schmidt, Andreas Mayerhofer, Anja Meyer et al.

Parkinson's disease is due to a dopamine deficiency caused by the degeneration of midbrain dopamine neurons. Current therapies are aimed to substitute dopamine or to directly stimulate postsynaptic dopamine receptors. However, not all patients profit from current therapies to the same extent, even serious side effects such as dyskinesias are complicating the therapy. Therefore, there is still a...